Financials iRhythm Technologies, Inc.

Equities

IRTC

US4500561067

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 21:00:00 17/07/2024 BST 5-day change 1st Jan Change
101.2 USD -3.59% Intraday chart for iRhythm Technologies, Inc. +6.74% -5.47%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,813 6,849 3,463 2,820 3,281 3,265 - -
Enterprise Value (EV) 1 1,827 6,793 3,357 2,642 3,280 3,291 3,286 3,251
P/E ratio -31.5 x -150 x -34 x -24.1 x -26.5 x -32.3 x -56.2 x -141 x
Yield - - - - - - - -
Capitalization / Revenue 8.45 x 25.8 x 10.7 x 6.86 x 6.66 x 5.59 x 4.74 x 4.03 x
EV / Revenue 8.52 x 25.6 x 10.4 x 6.43 x 6.66 x 5.64 x 4.77 x 4.02 x
EV / EBITDA -35.6 x -187 x -37.2 x -235 x -674 x 195 x 53.7 x 27.9 x
EV / FCF -43.2 x -249 x -51 x -50 x -36.2 x -39.9 x 1,280 x 44.2 x
FCF Yield -2.32% -0.4% -1.96% -2% -2.76% -2.51% 0.08% 2.26%
Price to Book 13.4 x 20.2 x 12.4 x 11.8 x 15.8 x 15.6 x 13.6 x 10.3 x
Nbr of stocks (in thousands) 26,624 28,871 29,426 30,111 30,651 31,105 - -
Reference price 2 68.09 237.2 117.7 93.67 107.0 105.0 105.0 105.0
Announcement Date 27/02/20 25/02/21 23/02/22 23/02/23 22/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 214.6 265.2 322.8 410.9 492.7 583.8 689.4 809.4
EBITDA 1 -51.31 -36.37 -90.28 -11.26 -4.863 16.91 61.15 116.7
EBIT 1 -54.76 -43.67 -99.94 -87.18 -125.2 -91.13 -55.22 -23.76
Operating Margin -25.52% -16.47% -30.96% -21.21% -25.4% -15.61% -8.01% -2.93%
Earnings before Tax (EBT) 1 -54.5 -43.6 -101 -115.9 -122.7 -97.68 -56.58 -25.65
Net income 1 -54.57 -43.83 -101.4 -116.2 -123.4 -97.91 -56.83 -19.59
Net margin -25.43% -16.53% -31.4% -28.27% -25.05% -16.77% -8.24% -2.42%
EPS 2 -2.160 -1.580 -3.460 -3.880 -4.040 -3.251 -1.867 -0.7425
Free Cash Flow 1 -42.32 -27.31 -65.82 -52.84 -90.52 -82.57 2.567 73.5
FCF margin -19.72% -10.3% -20.39% -12.86% -18.37% -14.14% 0.37% 9.08%
FCF Conversion (EBITDA) - - - - - - 4.2% 62.99%
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 27/02/20 25/02/21 23/02/22 23/02/23 22/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 81.8 92.38 102.1 103.9 112.6 111.4 124.1 124.6 132.5 131.9 146.2 147.4 158 156.3 172.5
EBITDA 1 -29.17 -4.753 -4.954 -2.624 1.069 -11.99 4.394 0.363 2.373 -12.12 0.2003 9.897 17.46 3.759 11.89
EBIT 1 -32.2 -21.8 -23.45 -21.09 -20.7 -39.5 -18.87 -27.6 -39.18 -38.14 -26.18 -15.85 -10.33 -24.3 -15.42
Operating Margin -39.36% -23.6% -22.98% -20.3% -18.38% -35.45% -15.2% -22.15% -29.57% -28.91% -17.9% -10.75% -6.54% -15.55% -8.94%
Earnings before Tax (EBT) 1 -32.43 -50.56 -23.86 -21.34 -20.12 -39.02 -18.27 -26.92 -38.44 -45.64 -26.58 -16.19 -10.76 -24.96 -14.97
Net income 1 -32.49 -50.61 -23.9 -21.45 -20.2 -39.11 -18.48 -27.12 -38.7 -45.67 -26.66 -16.26 -10.84 -25 -15.06
Net margin -39.72% -54.78% -23.42% -20.65% -17.94% -35.1% -14.89% -21.76% -29.2% -34.61% -18.23% -11.03% -6.86% -16% -8.73%
EPS 2 -1.100 -1.710 -0.8000 -0.7100 -0.6700 -1.290 -0.6100 -0.8900 -1.260 -1.470 -0.8757 -0.5557 -0.3814 -0.7140 -0.4640
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 23/02/22 05/05/22 04/08/22 01/11/22 23/02/23 04/05/23 03/08/23 02/11/23 22/02/24 02/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 14.5 - - - - 26.1 21.4 -
Net Cash position 1 - 55.6 106 178 1.22 - - 13.8
Leverage (Debt/EBITDA) -0.282 x - - - - 1.546 x 0.3498 x -
Free Cash Flow 1 -42.3 -27.3 -65.8 -52.8 -90.5 -82.6 2.57 73.5
ROE (net income / shareholders' equity) -58.2% -18.4% -32.6% -44.7% -54.9% -44.2% -22.1% -8.04%
ROA (Net income/ Total Assets) -25.8% -10.7% -20.8% -25.5% -28% -20.5% -10.8% -5.28%
Assets 1 211.9 408.9 487.4 455.6 440.7 476.8 525 371.1
Book Value Per Share 2 5.070 11.80 9.480 7.940 6.790 6.720 7.710 10.20
Cash Flow per Share - - - - - - - -
Capex 1 20.5 13.6 28.1 29.8 40.4 48 54.5 64
Capex / Sales 9.53% 5.11% 8.69% 7.26% 8.2% 8.22% 7.91% 7.91%
Announcement Date 27/02/20 25/02/21 23/02/22 23/02/23 22/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
105 USD
Average target price
132.6 USD
Spread / Average Target
+26.37%
Consensus
  1. Stock Market
  2. Equities
  3. IRTC Stock
  4. Financials iRhythm Technologies, Inc.